Product Program year 2020 Source: CMS Open Payments

Stingray

Device Vascular

Open in the dashboard

General payments

$83,623

482 payments

Research payments

$0

0 payments

Through program year 2020, $83,623 in general payments and $0 in research payments were reported against Stingray (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $13,753 141
2019 General $69,870 341

Breakdown

Who paid General payments · program years 2019–2020
  1. Boston Scientific Corporation $83,623 482 payments
Top recipients General payments · program year 2020
  1. Anbukarasi Maran Interventional Cardiology · Charleston, SC $3,200 23% · 1 payment
  2. Robert Riley Interventional Cardiology · Bellevue, WA $3,000 22% · 1 payment
  3. Nomen Azeem Interventional Pain Medicine · Riverview, FL $780 6% · 1 payment
  4. William Lombardi Interventional Cardiology · Seattle, WA $189 1% · 4 payments
  5. Rajiv Dhawan Cardiovascular Disease · Hanover, PA $149 1% · 4 payments

The top 5 of 85 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Interventional Cardiology Internal Medicine $10,473 77% · 51 practitioners
  2. Cardiovascular Disease Internal Medicine $2,004 15% · 26 practitioners
  3. Interventional Pain Medicine Pain Medicine $780 6% · 1 practitioner
  4. Advanced Heart Failure and Transplant Cardiology Internal Medicine $371 3% · 3 practitioners
  5. Ophthalmology $34 <1% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. South Carolina $3,200 23% · 1 recipient
  2. Ohio $3,011 22% · 2 recipients
  3. Pennsylvania $2,713 20% · 23 recipients
  4. New Jersey $1,747 13% · 15 recipients
  5. Florida $912 7% · 5 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

482 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record